DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Friday, 2 January 2015

1-(3,4-dimethoxyphenyl)ethanol





1-(3,4-dimethoxyphenyl)ethanol
Geza Arvai,

 http://www.google.com/patents/WO1999006343A1?cl=en


Example 1.
Into a 10-L hydrogenation vessel, equipped with an internal coil for heating and cooling, stirrer, manometer and thermometer, 3.5 kg (19,4 mol) of 3,4-dimethoxy- acetophenone are placed and to it 0.26 kg (0,074 mass part) slurry of finely- powdered Raney-nickel (pH=8-9) promoted catalyst are washed with 1 kg of water. The reactor is filled with 3.5 kg of water, flushed with nitrogen, then with hydrogen, and under intensive stirring (revolution per minute is approx. 1420 min"1) the mixture is reacted at 70-85°C with hydrogen under 8-10 bar. After 7 hours the hydrogen consumption is ceased. Closing the hydrogen inlet, the reaction is post- hydrogenated for half an hour, then it is cooled. The catalyst is removed by filtration. The filtrate is concentrated in vacuo (20 torr) by a rotary evaporator, in a 40-50°C water-bath. The product is a yellow viscous oil, weight 3.48 kg (19, 1 mol, 98,5%). Refractive index (NaD, 25°C) is 1,5385; assay by HPLC is 97,3%; water content by Karl-Fisher method is 1,2%. TLC (Kieselgel 60 F25 benzene-EtAc 7:3 v/v) shows one spot (Rf=0.28, visualized by UV light and PMA).
An aliquot part is crystallized from 1.5-fold volume of diethyl ether - light petroleum (2:1, v/v) mixture. Melting point of the thus obtained white crystals is 34- 35 °C.
Confirmation of structure
IR (KBr, cm"1) v: 3312, 3056, 3006, 2966, 2926, 2880, 2844, 1608, 1594, 1522, 1467, 1261, 1237, 1162, 1140, 1091, 1075, 1028, 861, 814.

 IH-NMR (200 MHz, CDC13) δ: 1.47 (3H, d, J=6.4 Hz, CH3), 2.08 (IH, s, OH),
3.86 and 3.88 (total 6H, each s, CH30), 4.83 (IH, q, J=6.4 Hz, CHOH), 6.79-6.93 (3H, m, aromatic).

1 C-NMR (50 MHz, CDCI3) δ: 25.05 (CH3), 55.79 and 55.89 (CH30), 70.10
(ArCH), 108.65 (C-2), 1 10.98 (C-5), 1 17.48 (C-6), 138.57 (C-l), 148.28 and 149.0 (C-3, C-4).



Literature data
CAS No: 5653-65-6
CA name: l-(3,4-dimethoxyphenyl)-ethanol B.p. 145-150 (4 torr), refractive index (Zhur. Obshchei Khim. 27, 2142 (1957), CA 52; 8089g) (NaD 20°C) 1.5440.
• IH-NMR (200 MHz, CDC13) δ: 1.48 (d, J=6.5 Hz), 3.86 and .89 (s), 4.84 (q), 6.8-6.94 (m).
• 13c-NMR (Ann- 1977- 588) (50 MHz' CDC13) δ: 25.0, 55.8, 55.9, 70.1, 108.7, 111.1, 117.5, 138.6, 148.4, 149.1.





Geza Arvai

process chemist at Sanofi

Geza Arvai

hu.linkedin.com/pub/geza-arvai/23/90a/165

Sanofi logo - Visszamegy home page


Üdvözöljük a Sanofi
magyarországi oldalán

Process for the preparation of 1-(3,4-dimethoxyphenyl)-ethanol(Link)

Europe WO9906343
Issued July 31, 1997
The subject of our invention is the process for the preparation of the 1-(3,4-dimethoxypheny)ethanol of formula (I), by the reduction of 3,4-dimethoxyacetophenone of formula (II), characterized in that the carbonyl group of the 3,4-dimethoxyacetophenone of formula (II) is reduced by 1 mol of hydrogen under the conditions of catalytic hydrogenation.
(Open)6 inventors, including:
  • Geza Arvai
    Geza Arvai
    process chemist at Sanofi
  • Béla Bertók
    Béla Bertók
    Project Supervisor at Cominnex Co Ltd.
  • No photo
    Aradi Mátyás
  • No photo
    Szalay Erzsébet

 .........
sanofi budapest





















Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)